Attention Investors
Kindly note the Change in PAY IN for BSE A/C No. : 1201250000000691 (CDSL), if you have an NSDL A/C, kindly use INTER DEPOSITORY SLIP. For assistance, please call OR contact: Mr. Dadu, 98339 89807 / 022-6145 1000.    |   Exchanges / Depository: Prevent Unauthorized Transactions in your Trading / Demat account --> Update your Mobile Numbers / email IDs with your Stock Brokers / Depository Participant. Receive alerts on your Registered Mobile / email IDs for trading account transactions and all debit and other important transactions in your demat account directly from Exchange / Depository on the same day ......................Issued in the interest of Investors."     |    KYC : "KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary."     |    ASBA-IPO : "No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."
 ««+1  ««-1
 
 
Syngene International LtdIndustry : Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code:539268NSE Symbol: SYNGENEP/E(TTM):56.6
ISIN Demat:INE398R01022Div & Yield %:1.87EPS(TTM):11.82
Book Value(Rs):104.1404189Market Cap ( Cr.):26931.74Face Value(Rs):10
    Change Company 
Date Headline
13-May-24 Syngene International Ltd - Syngene International Limited - Notice of Meeting
09-May-24 Syngene International Ltd - Syngene International Limited - Analysts/Institutional Investor Meet/Con. Call Updates
30-Apr-24 Syngene International Ltd - Syngene International Limited - Other General Purpose
29-Apr-24 Syngene International Ltd - Syngene International Limited - Copy of Newspaper Publication
26-Apr-24 Syngene International Ltd - Syngene International Limited - Analysts/Institutional Investor Meet/Con. Call Updates
25-Apr-24 Syngene International schedules AGM
25-Apr-24 Syngene International consolidated net profit rises 5.54% in the March 2024 quarter
25-Apr-24 Syngene Intl records PAT of Rs189 crore in Q4; EBITDA margin at 36%
25-Apr-24 Syngene International Ltd - Syngene International Limited - Outcome of Board Meeting
24-Apr-24 Board of Syngene International recommends final dividend
<< < 1 2 3 4   > >>